2012
DOI: 10.1177/0194599812457649
|View full text |Cite
|
Sign up to set email alerts
|

Incentive Spirometry for the Tracheostomy Patient

Abstract: This study supports the feasibility of using a customized incentive spirometer for tracheostomy patients and establishes a safety profile for the device to be used in future studies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
4
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(19 citation statements)
references
References 8 publications
1
4
0
Order By: Relevance
“…We observed MIV values ranging from 725 mL (600-820) to 870 mL (750-950). These values are consistent with those observed in earlier studies that reported values of maximal inspiratory volumes in tracheostomy patients that ranged from 250 mL to 1000 mL [21,31]. In contrast, when using the PED we observed greater inspiratory volumes.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…We observed MIV values ranging from 725 mL (600-820) to 870 mL (750-950). These values are consistent with those observed in earlier studies that reported values of maximal inspiratory volumes in tracheostomy patients that ranged from 250 mL to 1000 mL [21,31]. In contrast, when using the PED we observed greater inspiratory volumes.…”
Section: Discussionsupporting
confidence: 92%
“…Moreover, little is known on the optimal timing for performing the evaluations of these devices [18][19][20]. Therefore, the selection of the period for completing the evaluations of the device was based on the study by Goldstein et al [21] who reported a median intervention time of 1.6 days with a patient size equal to ours. In our pilot study, this period was increased to 3 days in order to observe changes in volume, pressure, chest X-ray, and arterial blood gas measurements.…”
Section: Introductionmentioning
confidence: 99%
“…Questions regarding clinical practice concepts such as aims, indications, contraindications, and instructions provided to patients for the use of ISs were based on the last clinical practice guideline for IS use 1 and on the paper by Armstrong. 3 For the contraindications, we have also used the study of Goldstein et al 15 to support the questionnaire's alternatives on IS use by patients with tracheostomy. Questions regarding the rationale behind the superiority of volume-oriented IS when compared to floworiented IS were based on the latest studies of Paisani et al, 11 Lunardi et al, 12 and Parreira et al 10…”
Section: Measuring Toolmentioning
confidence: 99%
“…It expands collapsed alveoli and improves chest wall function. [1] However, the spirometers commercially available cannot be used by tracheostomised patients because the mouth end of the spirometer cannot be connected to the tracheostomy tube [Figure 1]. The patient end of commercial incentive spirometers have a 'rectangular' cross-section which cannot fit to the spherical end of a tracheostomy tube.…”
mentioning
confidence: 99%
“…had developed a customised incentive spirometer for tracheostomised patients and concluded that incentive spirometry in tracheostomised patients was well tolerated with no complications. [1] Our modification in tracheostomised patients of cervical spine trauma, head and neck surgery patients and motor neuron disease patients is feasible.…”
mentioning
confidence: 99%